RT Journal Article
SR Electronic
T1 808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A906
OP A906
DO 10.1136/jitc-2023-SITC2023.0808
VO 11
IS Suppl 1
A1 Chaudhri, Apoorvi
A1 Bu, Xia
A1 Wang, Yunfei
A1 Hua, Ping
A1 Hung, Shao-Hsi
A1 Davies, Michael A
A1 Lizee, Gregory A
A1 Andrian, Ulrich von
A1 Hwu, Patrick
A1 Freeman, Gordon
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A906.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.